Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

LasX and Surnetics sign Memorandum of Understanding for Developing IVD and other Microfluidic Products

Published: Friday, September 06, 2013
Last Updated: Friday, September 06, 2013
Bookmark and Share
Companies are to partner on the development of precision-cut microfluidic products for use in the diagnostic, medical, and other life science markets.

LasX’s patented LaserSharp® laser digital converting technology is ideal for the high volume manufacturing of next-generation microfluidic platforms because of its unmatched precision. Laser converting technology delivers a more accurate, efficient, and flexible solution for processing today’s complex microfluidic products, from prototype to full-scale production.

Surnetics develops technology solutions for enabling and improving liquid flow within channels in microfluidic products. Surnetics has developed a patent portfolio for gradient coatings; for example, a coating that changes in hydrophilicity (or other properties) over the length of the channel. This technology allows for fluid to flow through a channel without the need for pumps, valves, wicking strips, or any other external force. The technology can be used to control flow features on a product while greatly reducing the cost and size of the product.

Tom Daul, Program Development Manager for LasX stated, “Together, these enabling technologies allow customers to achieve more accurate, cost-effective microfluidic platforms than ever before.” Brian Babcock, President and founder of Surnetics added, "We are very pleased to establish this relationship with LasX. They have been an industry leader in the manufacture of precision, high volume microfluidic products for life sciences and bring a great deal of product design and manufacturing expertise that can be combined with Surnetics’ expertise in coatings and fluid flow optimization. This agreement presents a tremendous opportunity for both companies to develop new product platforms using our combined capabilities.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More Than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
World’s Largest Coral Gene Database
‘Genetic toolkit’ will help shed light on which species survive climate change.
A Boost for Regenerative Medicine
Growing tissues and organs in the lab for transplantation into patients could become easier after scientists discovered an effective way to produce three-dimensional networks of blood vessels, vital for tissue survival yet a current stumbling block in regenerative medicine.
Breast Cancer Drug Hope
A drug for breast cancer that is more effective than existing medicines may be a step closer thanks to new research.
Untangling Disease-Related Protein Misfolding
Work advances understanding of genetic forms of thrombosis, emphysema, cirrhosis of the liver, neurodegenerative diseases and inflammation, among others.
Early Genetic Changes in Premalignant Colorectal Tissue Identified
Findings point to drivers of early cancer development, targets for cancer prevention therapies.
Harnessing Nature’s Vast Array of Venoms for Drug Discovery
Scripps scientists have developed a method for rapidly identifying venoms.
Nanoparticles Target, Transform Fat Tissue
Nanoparticles designed to target white fat and convert it to calorie-burning brown fat slowed weight gain in obese mice without affecting food intake. This proof-of-concept work could lead to new therapies to treat obesity.
New Cancer Fighters Emerge From Lab
Rice University lab simplifies total synthesis of anti-cancer agent.
Scientists Find Evidence That Cancer Can Arise Changes
Researchers at Rockefeller University have found a mutation that affects the proteins that package DNA without changing the DNA itself can cause a rare form of cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!